3 ms·
I'm not aware of any increase in risk of developing other allergies from the treatment. It is true that success is not guaranteed, however I believe the success
by modeless 3y ago
I'm not aware of any increase in risk of developing other allergies from the treatment. It is true that success is not guaranteed, however I believe the success rate is higher than that. Here's a study finding 76% effectiveness in dust mite allergies in adults. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705479/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705479/ And as I mentioned, I expect much higher effectiveness in children.
That said, the treatment does have risks and costs. It's certainly reasonable to decide against trying it. If your allergies cause asthma, Xolair and Dupixent are other options you can try. Combining Xolair or Dupixent with desensitization treatment is an exciting current area of research.
- d__a__n___g 3y ago[flagged]
- hdjjhhvvhga 3y ago> Xolair Unfortunately Omalizumab has some inherent risks and it's probably not something you'd consider first.
- modeless 3y agoTrue, Dupixent seems less risky. It really seems like a wonder drug to me. I'm excited for the results of the trials of Dupixent with OIT, especially since it treats EoE.
- deleted 3y ago[deleted]